(Q36591716)

15 August 2017

1 reference

title

Cardiovascular pharmacology and physiology of the isoprostanes (English)

1 reference

15 August 2017

1 reference

1

Jean-Luc Cracowski

1 reference

15 August 2017

Thierry Durand

2

1 reference

15 August 2017

1 October 2006

1 reference

Fundamental and Clinical Pharmacology

15 August 2017

1 reference

15 August 2017

20

1 reference

15 August 2017

5

1 reference

15 August 2017

417-427

1 reference

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Mechanisms for the formation of isoprostane endoperoxides from arachidonic acid. "Dioxetane" intermediate versus beta-fragmentation of peroxyl radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

A nomenclature system for the isoprostanes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Nomenclature of isoprostanes: a proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Induction of prostaglandin endoperoxide synthase-2 in human monocytes associated with cyclo-oxygenase-dependent F2-isoprostane formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Reduction of urinary 8-epi-prostaglandin F2 alpha during cyclo-oxygenase inhibition in rats but not in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Vascular biology of the isoprostanes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Thromboxane A(2) receptor mediated activation of the mitogen activated protein kinase cascades in human uterine smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Thromboxane A2 signalling in humans: a 'Tail' of two receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Vasoconstrictor effects of 8-iso-prostaglandin E2 and 8-iso-prostaglandin F(2alpha) on human umbilical vein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Characterization of the effects of isoprostanes on platelet aggregation in human whole blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Aspirin resistance: an evaluation of current evidence and measurement methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Aspirin insensitive eicosanoid biosynthesis in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

The 5-series F(2)-isoprostanes possess no vasomotor effects in the rat thoracic aorta, the human internal mammary artery and the human saphenous vein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

The Isoprostane 8-iso-PGE2Stimulates Endothelial Cells to Bind Monocytes via Cyclic AMP- and p38 MAP Kinase-Dependent Signaling Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

8-Iso-PGF2 alpha induces beta 2-integrin-mediated rapid adhesion of human polymorphonuclear neutrophils: a link between oxidative stress and ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Selective neuromicrovascular endothelial cell death by 8-Iso-prostaglandin F2alpha: possible role in ischemic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Isoprostaglandin E2 type-III (8-iso-prostaglandin E2) evoked contractions in the human internal mammary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Receptors and signaling pathway underlying relaxations to isoprostanes in canine and porcine airway smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Response of rat thoracic aorta to F(2)-isoprostane metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Increase of isoprostane 8-epi-PGF(2alpha)after restarting smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Passive cigarette smoking increases isoprostane formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Plasma F2-isoprostanes and coronary artery calcification: the CARDIA Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Thromboxane A(2) receptors mediate pulmonary hypertension in 60% oxygen-exposed newborn rats by a cyclooxygenase-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Improved endothelial function by the thromboxane A2 receptor antagonist S 18886 in patients with coronary artery disease treated with aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Effects of vitamin E on lipid peroxidation in healthy persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Pro-oxidant effect of vitamin E in cigarette smokers consuming a high polyunsaturated fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Effects of vitamin C and aspirin in ischemic stroke-related lipid peroxidation: results of the AVASAS (Aspirin Versus Ascorbic acid plus Aspirin in Stroke) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Faster plasma vitamin E disappearance in smokers is normalized by vitamin C supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Mediterranean vegetable soup consumption increases plasma vitamin C and decreases F2-isoprostanes, prostaglandin E2 and monocyte chemotactic protein-1 in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Flavanol-rich cocoa drink lowers plasma F(2)-isoprostane concentrations in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Oxidative stress in human hypertension: association with antihypertensive treatment, gender, nutrition, and lifestyle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Increased formation of F(2)-isoprostanes in patients with severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Increased urinary 15-F2t-isoprostane concentrations in patients with non-ischaemic congestive heart failure: a marker of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Increased urinary F2-isoprostanes in systemic sclerosis, but not in primary Raynaud's phenomenon: effect of cold exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Levels of F2-isoprostanes in systemic sclerosis: correlation with clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Postocclusive reactive hyperemia inversely correlates with urinary 15-F2t-isoprostane levels in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Increased lipid peroxidation correlates with platelet activation but not with markers of endothelial cell and blood coagulation activation in patients with antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Increased lipid peroxidation in patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Platelet activation and lipid peroxidation in patients with acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

No evidence for lipid peroxidation in severe preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Placental isoprostane is significantly increased in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Plasma, urinary, and salivary 8-epi-prostaglandin f2alpha levels in normotensive and preeclamptic pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

Elevated Levels of 8-iso-Prostaglandin F 2α in Pericardial Fluid of Patients With Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2006.00435.X

10.1111/J.1472-8206.2006.00435.X

21 January 2018

Identifiers

DOI

1 reference

release_n57v2x2swngxfjhva5wgr662de

15 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/n57v2x2swngxfjhva5wgr662de

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16968413

1 reference

PubMed ID

16968413